Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202

Abstract Purpose Trial*** was a phase III randomized trial designed to determine the optimal duration of androgen deprivation therapy (ADT) when combined with definitive radiation therapy (RT) in the treatment of locally advanced non-metastatic adenocarcinoma of the prostate. Long-term follow-up res...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of radiation oncology, biology, physics biology, physics, 2017-06, Vol.98 (2), p.296-303
Hauptverfasser: Lawton, Colleen A.F., MD, Lin, Xiaolei, MS, Hanks, Gerald E., MD, Lepor, Herbert, MD, Grignon, David J., MD, Brereton, Harmar D., MD, Bedi, Meena, MD, Rosenthal, Seth A., MD, Zeitzer, Kenneth L., MD, Venkatesan, Varagur M., MD, Horwitz, Eric M., MD, Pisansky, Thomas M., MD, Kim, Harold, MD, Parliament, Matthew B., MD, Rabinovitch, Rachel, MD, Roach, Mack, MD, Kwok, Young, MD, Dignam, James J., PhD, Sandler, Howard M., MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Purpose Trial*** was a phase III randomized trial designed to determine the optimal duration of androgen deprivation therapy (ADT) when combined with definitive radiation therapy (RT) in the treatment of locally advanced non-metastatic adenocarcinoma of the prostate. Long-term follow-up results of this study now available are relevant to the management of this disease. Materials and Methods Men (N=1,554) with adenocarcinoma of the prostate (cT2c-T4, N0-Nx) with a prostate specific antigen (PSA)
ISSN:0360-3016
1879-355X
DOI:10.1016/j.ijrobp.2017.02.004